Information requested to establish medical necessity (form prompts provider to confirm ALL of the following as applicable):
Diagnosis criteria: Provider must indicate diagnosis (HoFH or HeFH) and select supporting confirmation: for HoFH select any that apply — genetic confirmation of two mutant alleles (LDLR, Apo-B, PCSK9, LDLRAP1), cutaneous or tendon xanthoma before age 10, history of untreated LDL-C >500 mg/dL or treated LDL-C ≥300 mg/dL, or untreated elevated cholesterol in both parents; for HeFH select any that apply — genetic confirmation of one mutant allele (LDLR, Apo-B, PCSK9, LDLRAP1) or history of total cholesterol >290 mg/dL or LDL-C >190 mg/dL.
From diagnostic checklist on form
Family and clinical FH indicators: Provider must indicate presence or absence of Dutch Lipid Clinic Network score >8 and history of tendon xanthomas in the patient or first-/second-degree relatives.
Dutch score and family xanthoma questions on form
ASCVD events: Provider must indicate presence or absence of clinical atherosclerotic cardiovascular disease and select any qualifying events (e.g., acute coronary syndrome, MI, angina, revascularization, TIA, stroke, PAD) when relevant to the request.
ASCVD events listed on form
Current treatment with requested medication: Provider must state whether the patient is currently treated with the requested medication and provide start date if yes; if currently on another PCSK9 inhibitor, indicate whether that agent will be discontinued prior to starting the requested agent.
Questions 2 and 3
Statin therapy history: Provider must document statin use: whether patient is on high-intensity statin and adherent for the past 90 days or intolerant to high-intensity statin; if on low/moderate statin document adherence for past 90 days or intolerance defined as inability to tolerate lowest FDA starting dose to at least 2 different statins or FDA-labeled contraindication.90 days adherence look-back
Questions 4 and 5
LDL-C monitoring and response: Provide LDL-C value within the past 90 days and confirm whether the patient has achieved a 50% reduction in LDL-C from baseline while on a maximally tolerated statin; indicate if LDL-C has been ≥70 mg/dL in the past 90 days.LDL-C within 90 days; 50% reduction
Questions 6 and 7
Rationale and medication history: List reasons for selecting the requested medication (contraindications, allergies, adverse reactions, prior lower-dose trials), and provide complete prior and concurrent lipid-lowering therapies including failures.
Question 8 and medication history fields
Renewal requirements: For renewal requests, provider must confirm the patient has shown clinical benefit and has been adherent to the requested agent for the past 90 days and sign/date the form.90 days adherence
Renewal section